应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BBNX Beta Bionics, Inc.
盘后交易 09-18 19:15:55 EDT
23.05
-0.06
-0.26%
盘后
23.22
+0.17
+0.74%
17:32 EDT
最高
23.49
最低
22.76
成交量
88.42万
今开
23.35
昨收
23.11
日振幅
3.16%
总市值
10.02亿
流通市值
5.47亿
总股本
4,347万
成交额
2,037万
换手率
3.73%
流通股本
2,374万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Beta Bionics, Inc.2025财年第二财季实现净利润-16.87百万美元,同比减少16.67%
市场透视 · 08-02
Beta Bionics, Inc.2025财年第二财季实现净利润-16.87百万美元,同比减少16.67%
异动解读 | Beta Bionics股价盘中大涨10.98%,Truist证券上调目标价
异动解读 · 07-30
异动解读 | Beta Bionics股价盘中大涨10.98%,Truist证券上调目标价
异动解读 | 业绩超预期,Beta Bionics盘后大涨6.07%
异动解读 · 07-29
异动解读 | 业绩超预期,Beta Bionics盘后大涨6.07%
Beta Bionics(BBNX.US)获Truist Securities首次覆盖,给予买入评级, 目标价26.00美元。
金融界 · 06-16
Beta Bionics(BBNX.US)获Truist Securities首次覆盖,给予买入评级, 目标价26.00美元。
Beta Bionics获Wolfe Research首次覆盖,给予优于大市评级, 目标价20.00美元。
金融界 · 05-30
Beta Bionics获Wolfe Research首次覆盖,给予优于大市评级, 目标价20.00美元。
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
金融界 · 02-24
Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
金融界 · 02-24
Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
金融界 · 02-24
Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
金融界 · 02-24
Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。
加载更多
公司概况
公司名称:
Beta Bionics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。
发行价格:
--
{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":23.05,"timestamp":1758225600000,"preClose":23.11,"halted":0,"volume":884165,"hourTrading":{"tag":"盘后","latestPrice":23.22,"preClose":23.05,"latestTime":"17:32 EDT","volume":2594,"amount":59791.866016,"timestamp":1758231153592},"delay":0,"floatShares":23735244,"shares":43470125,"eps":-5.659705,"marketStatus":"盘后交易","change":-0.06,"latestTime":"09-18 19:15:55 EDT","open":23.35,"high":23.49,"low":22.76,"amount":20367966.22769,"amplitude":0.031588,"askPrice":23.22,"askSize":6,"bidPrice":22,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-5.659705,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1758240000000},"marketStatusCode":4,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":23.11,"postHourTrading":{"tag":"盘后","latestPrice":23.22,"preClose":23.05,"latestTime":"17:32 EDT","volume":2594,"amount":59791.866016,"timestamp":1758231153592},"volumeRatio":0.960896},"requestUrl":"/m/hq/s/BBNX","defaultTab":"news","newsList":[{"id":"2556846826","title":"Beta Bionics, Inc.2025财年第二财季实现净利润-16.87百万美元,同比减少16.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556846826","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556846826?lang=zh_cn&edition=full","pubTime":"2025-08-03 00:01","pubTimestamp":1754150479,"startTime":"0","endTime":"0","summary":"8月3日,Beta Bionics, Inc.公布财报,公告显示公司2025财年第二财季净利润为-16.87百万美元,同比减少16.67%;其中营业收入为23.24百万美元,同比增加54.42%,每股基本收益为-0.39美元。从资产负债表来看,Beta Bionics, Inc.总负债28.34百万美元,其中短期债务1.52百万美元,资产负债比为0.12,流动比率为0.15。机构评级:截至2025年8月3日,当前有9家机构对Beta Bionics, Inc.目标价做出预测,其中目标均价为23.67美元,其中最低目标价为17.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000154a6cf783e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803000154a6cf783e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"gpt_icon":0},{"id":"1103250329","title":"异动解读 | Beta Bionics股价盘中大涨10.98%,Truist证券上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1103250329","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103250329?lang=zh_cn&edition=full","pubTime":"2025-07-30 22:46","pubTimestamp":1753886790,"startTime":"0","endTime":"0","summary":"周三盘中,Beta Bionics股价大幅上涨10.98%,引起投资者广泛关注。推动Beta Bionics股价上涨的主要因素是华尔街分析师的积极评价。据悉,Truist Securities分析师于当日将Beta Bionics的目标价从18美元上调至21美元,这一举动显著提振了投资者信心。分析人士认为,Truist Securities上调目标价反映了对Beta Bionics公司未来发展前景的看好。作为一家专注于开发人工胰腺系统的医疗科技公司,Beta Bionics在糖尿病管理领域具有创新优势。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"1100799004","title":"异动解读 | 业绩超预期,Beta Bionics盘后大涨6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100799004","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100799004?lang=zh_cn&edition=full","pubTime":"2025-07-30 05:06","pubTimestamp":1753823186,"startTime":"0","endTime":"0","summary":"周二盘后,Beta Bionics, Inc.股价大涨6.07%,主要受益于公司发布的季度业绩报告好于市场预期。根据公司公布的财报,截至6月30日的季度调整后每股亏损为39美分,优于分析师平均预期的45美分亏损。值得注意的是,尽管Beta Bionics股价在本季度下跌了3.9%,但华尔街分析师对公司前景仍保持乐观。目前,分析师对该公司股票的平均评级为\"买入\",12个月目标价中位数为26.00美元,较最新收盘价13.99美元高出约46.2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"2544046746","title":"Beta Bionics(BBNX.US)获Truist Securities首次覆盖,给予买入评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544046746","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544046746?lang=zh_cn&edition=full","pubTime":"2025-06-17 00:20","pubTimestamp":1750090806,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Truist Securities首次覆盖,给予买入评级, 目标价26.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17002051100004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2539427938","title":"Beta Bionics获Wolfe Research首次覆盖,给予优于大市评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427938","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539427938?lang=zh_cn&edition=full","pubTime":"2025-05-30 23:44","pubTimestamp":1748619866,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Wolfe Research首次覆盖,给予优于大市评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023493495086e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053023493495086e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX"],"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513777845?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖,给予买入评级, 目标价25.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722329?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖,给予买入评级, 目标价30.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513272995?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖,给予增持评级, 目标价26.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513723151?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖,给予优于大市评级, 目标价28.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":-0.0708},{"period":"1month","weight":0.3389},{"period":"3month","weight":0.2998},{"period":"6month","weight":0.5305},{"period":"1year","weight":0.3594},{"period":"ytd","weight":0.3594}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.1033},{"period":"6month","weight":0.1688},{"period":"1year","weight":0.1707},{"period":"ytd","weight":0.1247}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立,并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司,从事创新解决方案的设计、开发和商业化,通过利用先进的自适应闭环算法简化和改善其疾病的治疗,提高胰岛素需求糖尿病患者的健康和生活质量。","exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}